|
|
|
|
|
|
|
Indonesia sends bird flu samples to WHO
Feb 21 2008 11:51PM (CT)
JAKARTA, Indonesia (AP) - Indonesia sent 12 bird flu samples to a World Health Organization laboratory this week after receiving assurances its rights to any vaccines produced from them would be recognized, the health minister said.
|
|
|
Naps, mammograms may predict stroke risk
Feb 21 2008 11:03PM (CT)
NEW ORLEANS (AP) - What do mammograms, blood-sugar tests and daytime dozing have in common? All may offer clues that someone is headed for a stroke, new studies suggest. Higher stroke risk was seen in women with artery buildups accidentally revealed by mammograms, in non-diabetics starting to have insulin problems, and in older people who tend to nod off a lot.
|
|
|
Just 1 in 4 know heart attack signs
Feb 21 2008 9:02PM (CT)
ATLANTA (AP) - Only about 1 in 4 Americans know the warning signs of a heart attack and what to do first, according to a new government report. That's a decline in knowledge since the last survey in 2001, which showed nearly 1 in 3 to be well informed.
|
|
|
Feds prescribe new recipe for flu shot
Feb 21 2008 7:43PM (CT)
WASHINGTON (AP) - Next year's flu vaccine is getting a complete overhaul to provide protection against three new and different influenza strains _ hopefully better protection than this year's version.
|
|
|
FDA clears Wyeth drug for hemophilia
Feb 21 2008 5:33PM (CT)
WASHINGTON (AP) - Federal regulators approved a Wyeth drug Thursday to prevent and control bleeding in patients with a rare blood-clotting disorder.
|
|
|
States redefine family health policies
Feb 21 2008 1:46PM (CT)
WASHINGTON (AP) - Thomas Mahoney came out of a seizure last December surrounded by paramedics ready to take him to the hospital by ambulance. Mindful of the cost, he asked his mom and girlfriend to drive him instead, slipping in and out of consciousness along the way.
|
|
|
Cancer drug ruling will have wide impact
Feb 21 2008 12:44PM (CT)
WASHINGTON (AP) - A decision expected Friday on federal approval for Genentech's Avastin cancer drug could have ramifications for all companies developing cancer medicines.
|
|
|
|
|
|